Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

20,711 total articles

Qfin Holdings Announces Second Quarter and Interim 2026 Unaudited Financial Results and Declares Semi-Annual Dividend

Qfin Holdings Announces Second Quarter and Interim 2026 Unaudited Financial Results and Declares Semi-Annual Dividend

Qfin Holdings, a leading AI-powered credit technology platform in China, announced its unaudited Q2 and interim 2026 financial results. The company experienced declines in loan facilitation volume, revenue, and net income compared to prior periods due to industry contraction, regulatory pressure, and liquidity shocks. Despite these headwinds, Qfin …

Greenland Mines Announces Proposed Public Offering

Greenland Mines Announces Proposed Public Offering

Greenland Mines Ltd, a Nasdaq-listed critical minerals developer, announced its intention to conduct a public offering of common stock to raise funds for acquiring the Sarfartoq Nd-Pr Rare Earth Element Project, along with supporting working capital and general corporate purposes. The offering is subject to market conditions and regulatory approval…

F&M Bank Welcomes Gregory R. Allen to Board of Directors

F&M Bank Welcomes Gregory R. Allen to Board of Directors

Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO), parent of F&M Bank, announced the retirement of longtime board member Andrew J. Briggs and the appointment of Gregory R. Allen to its Board of Directors. Allen brings extensive banking and economic development experience, reinforcing the bank's commitment to community-oriented banking and strategic …

Renasant Announces Chief Financial Officer Transition

Renasant Announces Chief Financial Officer Transition

Renasant Corporation announced that Catherine Mealor will join as Executive Vice President and Chief Financial Officer starting January 1, 2027. Incumbent CFO Jim Mabry, who has led since August 2020, will retire early 2027 but remain nominated for the Board of Directors. Mealor brings over 20 years of financial services expertise and research back…

Par Pacific Announces Agreement to Sell Laramie Energy Assets

Par Pacific Announces Agreement to Sell Laramie Energy Assets

Par Pacific Holdings announced that Laramie Energy, in which it owns a 46% stake, has agreed to sell most of its oil and gas assets for $485 million in cash. Par Pacific expects to receive about $146 million net from the transaction and anticipates exiting its investment in Laramie Energy. The deal is expected to close by the end of 2026, subject t…

BJ’s Restaurants, Inc. to Participate at the 19th Annual Barclays Global Consumer Staples Conference

BJ’s Restaurants, Inc. to Participate at the 19th Annual Barclays Global Consumer Staples Conference

BJ's Restaurants, Inc. announced that its management team will participate in a fireside discussion at the 19th Annual Barclays Global Consumer Staples Conference in Boston on September 8, 2026. The event will be webcast live and rebroadcast on the company's investor relations website. BJ's Restaurants is a national casual dining brand known for it…

ThredUp Releases Fifth Annual Impact Report

ThredUp Releases Fifth Annual Impact Report

ThredUp released its fifth annual Impact Report detailing its environmental, social, and governance efforts and progress throughout 2025. The company processed over 261 million secondhand items since inception, recirculated 90% of inventory in 2025, and expanded its Resale-as-a-Service partnerships. It reported significant environmental savings inc…

nCino Reports Second Quarter Fiscal Year 2027 Financial Results

nCino Reports Second Quarter Fiscal Year 2027 Financial Results

nCino, Inc. announced its Q2 FY2027 financial results, reporting 8% total revenue growth year-over-year to $161 million, with subscription revenues up 10%. The company showed a significant GAAP operating margin improvement to 8% and a non-GAAP operating margin of 25%. Free cash flow increased 170% to $34 million. Additionally, nCino's Board authori…

SL Green Realty Corp. to Present at the BofA Securities 2026 Global Real Estate Conference on September 15, 2026

SL Green Realty Corp. to Present at the BofA Securities 2026 Global Real Estate Conference on September 15, 2026

SL Green Realty Corp., Manhattan's largest office landlord and a publicly traded REIT, announced that key executives will participate in a roundtable at the upcoming BofA Securities 2026 Global Real Estate Conference. The event will be webcast live on September 15, 2026. The company highlighted its substantial portfolio and discussed various forwar…

ABM to Announce Third Quarter 2026 Financial Results

ABM to Announce Third Quarter 2026 Financial Results

ABM Industries, a leading provider of integrated facility solutions, announced it will release its fiscal Q3 2026 financial results before market open on September 8, 2026. The company will also host a conference call and webcast to discuss the results, providing insights into its performance and strategic outlook.

Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026

Ascendis Announces Oral Presentation of Week 104 Data from Its Pivotal Trial of TransCon® CNP (Navepegritide) at ISDS 2026

Ascendis Pharma announced that it will present Week 104 data from its pivotal ApproaCH Trial of once-weekly TransCon CNP (navepegritide) at the ISDS 2026 meeting. The data show durable improvements in growth and multiple physical functioning parameters in children with achondroplasia, alongside a safety profile similar to placebo. The FDA has appro…

Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-study of the SKYWAY Phase 2 Trial of SPY072

Spyre Therapeutics Announces Topline Results from the Rheumatoid Arthritis Sub-study of the SKYWAY Phase 2 Trial of SPY072

Spyre Therapeutics announced promising topline results from the RA sub-study of its Phase 2 SKYWAY trial evaluating SPY072. Both low and high doses of SPY072 showed statistically significant improvements versus placebo on key efficacy endpoints with a favorable safety profile. However, the magnitude of effect did not meet the company's internal thr…